Association of Genetic Variants of Klotho with BP Responses to Dietary Sodium or Potassium Intervention and Long-Term BP Progression
<b><i>Objectives:</i></b> Klotho (<i>KL</i>) plays pivotal roles in the progression of salt-sensitive hypertension. Salt-sensitive hypertension was associated with <i>KL</i> genotypes. We aimed to explore the association of common genetic variants of <i>KL</i> with individual blood pressure (BP) responses to sodium and potassium through a dietary intervention study as well as long-term BP progression. <b><i>Methods:</i></b> We conducted family-based dietary interventions among 344 participants from 126 families in rural villages of northern China in 2004. Subjects sequentially underwent a baseline diet, a low-salt diet (51.3 mmol/day Na), a high-salt diet (307.8 mmol/day Na), and a high-salt + potassium supplementation diet (307.8 mmol/day Na + 60 mmol/day K). After dietary intervention, we followed up with these participants in 2009 and 2012. The associations between 6 single-nucleotide polymorphisms (SNPs) of <i>KL</i> and phenotypes were analyzed through a linear mixed-effects model. <b><i>Results:</i></b> SNPs rs211247 and rs1207568 were positively correlated with the BP response to high-salt diet in the dominant model after adjusting for confounders (β = 1.670 and 2.163, <i>p</i> = 0.032 and 0.005, respectively). BPs rs526906 and rs525014 were in a haplotype block. Block rs526906-rs525014 was positively correlated with diastolic BP response to potassium and potassium sensitivity in the additive model (β = 0.845, <i>p</i> = 0.032). In addition, regression analysis indicated that rs211247 was associated with long-term systolic BP alterations after 8 years of follow-up in the recessive model (β = 20.47, <i>p</i> = 0.032). <b><i>Conclusions:</i></b> Common variants of the <i>KL</i> gene might modify individual BP sensitivity to sodium or potassium and influence the long-term progression of BP, suggesting a potential role in the development of salt-sensitive hypertension. Thus, <i>KL</i> may be a new early intervention target for salt-sensitive hypertension.